Quality of Earnings (QoE) Lab

Model Quality of Earnings (QoE), EBITDA normalization bridges, cash conversion quality, and Sloan accrual anomaly detection in M&A due diligence.

Scenario presets

Reported Financials & Due Diligence Adjustments

Primary QoE & Earnings Quality Indicators

Normalized Adjusted EBITDA
$12,500,000
+25.0% Net Normalization Uplift
Cash Conversion Ratio
1.25x
CFO Exceeds Net Income
Sloan Accrual Anomaly Ratio
-3.75%
Conservative Accrual Quality
Effective EV / Adjusted EBITDA
8.00x
vs 10.00x on Reported EBITDA

Valuation & Due Diligence Sensitivity Matrices

Matrix 1: Normalized EBITDA ($) vs Reported & Add-backs

Varying Reported EBITDA (±20%) vs Due Diligence Add-backs (±20%).

Matrix 2: True Purchase Multiple (EV / Adj EBITDA)

Effective valuation multiple paid across purchase prices and normalized earnings.

Comprehensive Quality of Earnings & Accrual Reconciliation Schedule

Step-by-Step Worked Calculation Example

Follow this end-to-end mathematical walkthrough using our baseline parameters to audit each intermediate metric.

  1. Calculate Normalized Adjusted EBITDA:
    Adjusted EBITDA = Reported EBITDA ($10,000,000) + Net Due Diligence Add-Backs ($2,500,000) = $12,500,000.
    Normalization Uplift = ($2,500,000 / $10,000,000) × 100% = +25.00%.
  2. Calculate Cash-to-Net-Income Conversion Ratio:
    Cash Conversion = Operating Cash Flow ($7,500,000) / Net Income ($6,000,000) = 1.25x. Because this exceeds 1.0x, reported net income is conservatively backed by liquid customer collections.
  3. Calculate Sloan Accrual Anomaly Ratio:
    Accrual Spread = Net Income ($6,000,000) - Operating Cash Flow ($7,500,000) = -$1,500,000.
    Sloan Accrual Ratio = (-$1,500,000 / $40,000,000 Average Assets) × 100% = -3.75%. A negative accrual ratio is a strong indicator of high earnings quality and zero aggressive revenue inflation.
  4. Determine Valuation Multiple Impact:
    Reported Multiple = Enterprise Value ($100,000,000) / Reported EBITDA ($10,000,000) = 10.00x.
    Effective Adjusted Multiple = $100,000,000 / $12,500,000 = 8.00x.
    Valuation Multiple Relief = 10.00x - 8.00x = 2.00x multiple reduction. The buyer is effectively paying 8.0x normalized cash earnings rather than the headline 10.0x.

Interactive Concept Self-Check Quiz

1. What is the primary purpose of a Quality of Earnings (QoE) report in private equity acquisitions?

2. What does an Accrual Ratio of +12.0% (Net Income >> CFO) indicate to an M&A transaction team?

3. If a target reports $8M EBITDA but QoE due diligence reveals $2M of non-recurring owner personal perks, what is Adjusted EBITDA?

4. How does an EBITDA add-back impact the buyer's effective valuation multiple at a fixed purchase price?

Frequently Asked Questions

A Quality of Earnings (QoE) analysis evaluates the repeatability, sustainability, and cash-backing of a company's reported financial performance. Conducted during M&A due diligence, it adjusts reported EBITDA for non-recurring expenses, owner perks, and pro-forma run-rate changes to establish the true ongoing cash earnings available to a buyer.

Reported EBITDA reflects historical GAAP or IFRS accounting results, which may include one-time legal settlements, owner personal expenses, PPP loan forgiveness, or restructuring costs. Adjusted EBITDA normalizes these items, adding back discretionary or non-recurring expenses to reflect true baseline operating earning power.

The cash-to-net-income conversion ratio (CFO / Net Income) measures the percentage of accounting profit that converts into liquid operating cash. A ratio consistently above 1.0x indicates high-quality, cash-generative earnings. A ratio below 1.0x warns that reported profits are tied up in uncollected receivables or inventory build-ups.

The Accrual Anomaly (or Sloan Accrual Ratio) measures the portion of net income driven by non-cash accruals relative to total assets: Accrual Ratio = (Net Income - Operating Cash Flow) / Total Assets. High positive accruals indicate aggressive revenue recognition or capitalized operating costs, historically correlating with future earnings disappointments and stock underperformance.